Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F N Rutledge

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Bailliere'S Clinical Obstetrics and Gynaecology|December 1, 1988
Management of para-aortic nodal metastases from carcinoma of the cervixF N Rutledge
Bailliere'S Clinical Obstetrics and Gynaecology|March 1, 1989
The second-look operation for ovarian cancerF N Rutledge
AJR. American Journal of Roentgenology|December 1, 1976
ARS Presidential Address: Estrogen therapy: a causal role in endometrial cancer?F N Rutledge
Obstetrics and Gynecology|November 1, 1972
The gynecologic oncologist. His responsibilities and trainingF N Rutledge
American Journal of Obstetrics and Gynecology|June 1, 1989
Hazards of clinical investigationF N Rutledge
National Cancer Institute Monograph|October 1, 1975
Chemotherapy in advanced ovarian cancerJ P Smith, F N Rutledge
National Cancer Institute Monograph|October 1, 1975
Random study of hexamethylmelamine, 5-fluorouracil, and melphalan in treatment of advanced carcinoma of the ovaryJ P Smith, F N Rutledge
American Journal of Obstetrics and Gynecology|May 1, 1974
Urinary conduit in pelvic cancer patients. A report of 16 years' experienceR W Swan, F N Rutledge
Clinical Obstetrics and Gynecology|June 1, 1973
Metastatic ovarian cancerJ P Smith, F N Rutledge
Gynecologic Oncology|March 1, 1987
Pelvic exenteration: prognostic significance of regional lymph node metastasisF N Rutledge, V B McGuffee
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Bailliere'S Clinical Obstetrics and Gynaecology|December 1, 1988
Management of para-aortic nodal metastases from carcinoma of the cervixF N Rutledge
Bailliere'S Clinical Obstetrics and Gynaecology|March 1, 1989
The second-look operation for ovarian cancerF N Rutledge
AJR. American Journal of Roentgenology|December 1, 1976
ARS Presidential Address: Estrogen therapy: a causal role in endometrial cancer?F N Rutledge
Obstetrics and Gynecology|November 1, 1972
The gynecologic oncologist. His responsibilities and trainingF N Rutledge
American Journal of Obstetrics and Gynecology|June 1, 1989
Hazards of clinical investigationF N Rutledge
National Cancer Institute Monograph|October 1, 1975
Chemotherapy in advanced ovarian cancerJ P Smith, F N Rutledge
National Cancer Institute Monograph|October 1, 1975
Random study of hexamethylmelamine, 5-fluorouracil, and melphalan in treatment of advanced carcinoma of the ovaryJ P Smith, F N Rutledge
American Journal of Obstetrics and Gynecology|May 1, 1974
Urinary conduit in pelvic cancer patients. A report of 16 years' experienceR W Swan, F N Rutledge
Clinical Obstetrics and Gynecology|June 1, 1973
Metastatic ovarian cancerJ P Smith, F N Rutledge
Gynecologic Oncology|March 1, 1987
Pelvic exenteration: prognostic significance of regional lymph node metastasisF N Rutledge, V B McGuffee
Pageof 9